๐ฐ Ellipses Pharma News
Page 3 - Ellipses Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ellipses Pharma. Real-time updates on events, politics, business and more.
December 21, 2022
/PRNewswire/ -- DelveInsights Gastric Cancer Pipeline Insight โ 2022 report provides comprehensive global coverage of available, marketed, and pipeline...
November 21, 2022
Ellipses Pharma Limited (โEllipsesโ), a global drug development company focused on accelerating the development of new oncology treatments, is delighted to announce that it will be presenting clinical updates covering two of its assets at the San Antonio Breast Cancer Symposium (SABCS), taking place between 6 โ 10 ...
June 23, 2022
The US FDA has approved Ellipses Pharmaโs investigational new drug (IND) application for EP0031 (A400) to treat advanced RET-altered cancers.
June 22, 2022
A phase 1/2 trial to initiate across a range of patient populations with RET-altered cancers Ellipses Pharma ("Ellipses"), a global drug development company focused on accelerating the development
May 25, 2022
Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours SunRock Biopharma S.L. ("SunRock"), a biopharmaceutical company that is developing a portfolio
May 25, 2022
Ellipses Pharma and SunRock Biopharma enter into a licensing agreement for a first-in-class bifunctional HER3:TRAIL fusion protein Ellipses Pharma granted exclusive global rights to develop and commercialise SRB22, in solid tumours LONDON and SANTIAGO DE COMPOSTELA, Spain, May 25, 2022: SunRock Biopharma S...
December 22, 2021
Igraine Plc - Audited Results to 31 December 2020 PR Newswire London, December 22 IGRAINE PLC AQSE: KING ("Igraine" or the "Company") Audited Final Results
December 22, 2021
Igraine Plc - Interim Results to 30 June 2021 PR Newswire London, December 22 THE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE
June 11, 2021
DiscovOre Plc - Conditional Subscription with Angelfish Investments plc PR Newswire London, June 11 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY
June 11, 2021
Investegate announcements from Angelfish Inv. PLC, Notice of GM, Board Changes and Change of Adviser